Amarin Corporation plc

The momentum for this stock is not very good. Amarin Corporation plc has good growth characteristics. Amarin Corporation plc is not very popular among insiders. Amarin Corporation plc is a mediocre stock to choose.
Log in to see more information.
Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and developm...
AMRN Fundamental Data by TradingView

News

Research Highlighting the Clinical Impact of VASCEPA /VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicos
Research Highlighting the Clinical Impact of VASCEPA /VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicos

Globe Newswire DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that new supported and/or funded research on the clinical impact of...\n more…

Amarin (NASDAQ:AMRN) & SIGA Technologies (NASDAQ:SIGA) Financial Survey
Amarin (NASDAQ:AMRN) & SIGA Technologies (NASDAQ:SIGA) Financial Survey

Zolmax Amarin (NASDAQ:AMRN - Get Free Report) and SIGA Technologies (NASDAQ:SIGA - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies...\n more…

Zacks Research Research Analysts Lift Earnings Estimates for Amarin Co. plc (NASDAQ:AMRN)
Zacks Research Research Analysts Lift Earnings Estimates for Amarin Co. plc (NASDAQ:AMRN)

Ticker Report Amarin Co. plc (NASDAQ:AMRN - Free Report) - Research analysts at Zacks Research boosted their Q3 2024 EPS estimates for Amarin in a note issued to investors on Wednesday, August 21st. Zacks Research...\n more…

Latest Research Highlighting VASCEPA /VAZKEPA (icosapent ethyl) REDUCE-IT Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of
Latest Research Highlighting VASCEPA /VAZKEPA (icosapent ethyl) REDUCE-IT Subgroup Data and New Mechanistic Insights into Eicosapentaenoic Acid (EPA) to be Presented at European Society of

Globe Newswire DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded subgroup data from the landmark REDUCE-IT...\n more…

Amarin Co. plc (NASDAQ:AMRN) CEO Aaron Berg Purchases 160,000 Shares of Stock
Amarin Co. plc (NASDAQ:AMRN) CEO Aaron Berg Purchases 160,000 Shares of Stock

Ticker Report Amarin Co. plc (NASDAQ:AMRN - Get Free Report) CEO Aaron Berg bought 160,000 shares of Amarin stock in a transaction dated Friday, August 2nd. The stock was acquired at an average cost of $0.64 per...\n more…

Amarin Co. plc Forecasted to Earn FY2024 Earnings of ($0.13) Per Share (NASDAQ:AMRN)
Amarin Co. plc Forecasted to Earn FY2024 Earnings of ($0.13) Per Share (NASDAQ:AMRN)

Zolmax Amarin Co. plc (NASDAQ:AMRN - Free Report) - Analysts at Cantor Fitzgerald upped their FY2024 earnings per share (EPS) estimates for shares of Amarin in a research note issued on Thursday, August...\n more…